Lifevantage Corporation
LFVN
$5.15
$0.010.20%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -12.15% | -0.99% | 16.77% | 14.17% | 8.22% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -12.15% | -0.99% | 16.77% | 14.17% | 8.22% |
| Cost of Revenue | -2.55% | 4.12% | 10.72% | 8.26% | 3.14% |
| Gross Profit | -14.51% | -2.29% | 18.35% | 15.71% | 9.55% |
| SG&A Expenses | -11.69% | -1.09% | 15.26% | 11.06% | 3.91% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -9.78% | 0.02% | 14.28% | 10.47% | 3.74% |
| Operating Income | -50.51% | -19.85% | 93.35% | 181.60% | 257.54% |
| Income Before Tax | -46.12% | -9.80% | 95.24% | 181.51% | 199.43% |
| Income Tax Expenses | -70.24% | -51.67% | -9.78% | 72.66% | 471.64% |
| Earnings from Continuing Operations | -37.14% | 7.08% | 145.14% | 233.84% | 154.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -37.14% | 7.08% | 145.14% | 233.84% | 154.34% |
| EBIT | -50.51% | -19.85% | 93.35% | 181.60% | 257.54% |
| EBITDA | -42.86% | -17.96% | 54.64% | 94.05% | 121.52% |
| EPS Basic | -38.05% | 6.11% | 143.27% | 235.35% | 159.62% |
| Normalized Basic EPS | -48.21% | -13.17% | 93.50% | 182.17% | 237.71% |
| EPS Diluted | -35.37% | 6.74% | 141.14% | 222.91% | 152.73% |
| Normalized Diluted EPS | -46.82% | -13.58% | 91.79% | 179.29% | 232.15% |
| Average Basic Shares Outstanding | 2.07% | 1.35% | -0.34% | -1.57% | -2.41% |
| Average Diluted Shares Outstanding | -1.32% | 0.51% | 2.46% | 1.66% | 0.93% |
| Dividend Per Share | 12.50% | 12.90% | 13.33% | 13.79% | 14.29% |
| Payout Ratio | 0.81% | 0.06% | -0.54% | -0.91% | -0.89% |